Fingerprint
Dive into the research topics of 'Activity and safety of mobocertinib (Tak-788) in previously treated non–small cell lung cancer with egfr exon 20 insertion mutations from a phase i/ii trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically